Works by Sluiter, Wim


Results: 84
    1
    2
    3
    4

    <sup>89</sup>Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.

    Published in:
    Journal of Nuclear Medicine, 2016, v. 57, n. 8, p. 1244, doi. 10.2967/jnumed.115.167643
    By:
    • Oosting, Sjoukje F.;
    • van Asselt, Sophie J.;
    • Brouwers, Adrienne H.;
    • Bongaerts, Alfons H.H.;
    • Steinberg, Julia D.J.;
    • de Jong, Johan R.;
    • Lub-de Hooge, Marjolijn N.;
    • van der Horst-Schrivers, Anouk N.A.;
    • Walenkamp, Annemiek M.E.;
    • Hoving, Eelco W.;
    • Sluiter, Wim J.;
    • Zonnenberg, Bernard A.;
    • de Vries, Elisabeth G.E.;
    • Links, Thera P.
    Publication type:
    Article
    5

    <sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.

    Published in:
    Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 63, doi. 10.2967/jnumed.114.144840
    By:
    • Oosting, Sjoukje F.;
    • Brouwers, Adrienne H.;
    • van Es, Suzanne C.;
    • Nagengast, Wouter B.;
    • Munnink, Thijs H. Oude;
    • Lub-de Hooge, Marjolijn N.;
    • Hollema, Harry;
    • de Jong, Johan R.;
    • de Jong, Igle J.;
    • de Haas, Sanne;
    • Scherer, Stefan J.;
    • Sluiter, Wim J.;
    • Dierckx, Rudi A.;
    • Bongaerts, Alfons H. H.;
    • Gietema, Jourik A.;
    • de Vries, Elisabeth G. E.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Arterial wall strength after endovascular photodynamic therapy.

    Published in:
    Lasers in Surgery & Medicine, 2003, v. 33, n. 1, p. 8, doi. 10.1002/lsm.10187
    By:
    • Edward E.E. Gabeler;
    • Richard van Hillegersberg;
    • Wim Sluiter;
    • Mike Kliffen;
    • Randolph G. Statius van Eps;
    • Jan Honkoop;
    • Stephane G. Carlier;
    • Hero van Urk
    Publication type:
    Article
    18
    19
    20
    21
    22

    Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the –629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients

    Published in:
    Clinical Endocrinology, 2008, v. 69, n. 3, p. 359, doi. 10.1111/j.1365-2265.2008.03196.x
    By:
    • Dullaart, Robin P. F.;
    • Schols, Jeroen L.;
    • van der Steege, Gerrit;
    • Zelissen, Peter M. J.;
    • Sluiter, Wim J.;
    • van Beek, André P.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    Similar Adverse Pregnancy Outcome in Native and Nonnative Dutch Women with Pregestational Type 2 Diabetes: A Multicentre Retrospective Study.

    Published in:
    ISRN Obstetrics & Gynecology, 2013, p. 1, doi. 10.1155/2013/361435
    By:
    • Groen, Bart;
    • Links, Thera P.;
    • van den Berg, Paul P.;
    • Hellinga, Marieke;
    • Moerman, Sharon;
    • Visser, Gerard H. A.;
    • Sluiter, Wim J.;
    • Faas, Marijke M.;
    • Schreuder, Manon C. J.;
    • Visser, Willy;
    • Geelhoed-Duijvestijn, Petronella H. L. M.;
    • Bianchi, Rutgert;
    • Bartelink, Anton K. M.;
    • de Valk, Harold W.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between <sup>99m</sup>Tc-sestamibi/<sup>18</sup>F-FDG DISA SPECT and <sup>13</sup>N-ammonia/<sup>18</sup>F-FDG PET

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 6, p. 716, doi. 10.1007/s00259-005-0016-z
    By:
    • Riemer H. J. A.Start;
    • Bax, Jeroen J.;
    • van Veldhuisen, Dirk J.;
    • van der Wall, Ernst E.;
    • Irwan, Roy;
    • Sluiter, Wim J.;
    • Dierckx, Rudi A.;
    • de Boer, Jaep;
    • Jager, Pieter L.
    Publication type:
    Article
    39

    P53-specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy.

    Published in:
    International Journal of Cancer, 2007, v. 121, n. 3, p. 606, doi. 10.1002/ijc.22710
    By:
    • Lambeck, Annechien;
    • Leffers, Ninke;
    • Hoogeboom, Baukje-Nynke;
    • Sluiter, Wim;
    • Hamming, Ineke;
    • Klip, Harry;
    • ten Hoor, Klaske;
    • Esajas, Martha;
    • van Oven, Magda;
    • Drijfhout, Jan-Wouter;
    • Platteel, Inge;
    • Offringa, Rienk;
    • Hollema, Harry;
    • Melief, Kees;
    • van der Burg, Sjoerd;
    • van der Zee, Ate;
    • Daemen, Toos;
    • Nijman, Hans
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50